Glutathione tablet 500 mg are an oral antioxidant supplement. The core component is a naturally occurring tripeptide molecule within human cells. Each tablet provides a standardized dose of 500 milligrams, aiming to conveniently support the body's own antioxidant defense system. It is taken orally and its main effects include neutralizing free radicals to reduce oxidative stress, assisting the liver's detoxification process to promote toxin metabolism, and supporting the normal function of the immune system. The tablet form is convenient to carry and take in measured quantities. However, it should be noted that its absorption efficiency is affected by an individual's digestive ability and product formulation technology (such as whether it uses enhanced absorption processes). This product is suitable for those who wish to support overall antioxidant health through daily supplementation, especially those who pay attention to liver care and skin health. It is recommended to consult a medical professional before use.
They offer a convenient way to replenish these stores. By enhancing intracellular glutathione, they help reduce oxidative stress, protect mitochondria from damage, and support energy production. Studies suggest that glutathione supplementation may aid muscle recovery after exercise by mitigating inflammation and promoting protein synthesis via pathways like mTOR. Additionally, glutathione supports liver detoxification, skin health, and immune resilience.
However, it has poor oral bioavailability in its reduced form, so many tablets use precursors like N-acetylcysteine (NAC) or liposomal formulations to improve absorption. Users often report benefits such as faster recovery, reduced fatigue, and improved overall well-being. While generally safe, those with pre-existing conditions or on medication should consult a healthcare provider before use. Paired with a balanced diet and healthy lifestyle, it can be a valuable tool for optimizing antioxidant status and long-term health.
Our product
At the same time, our company not only provides glutathione tablet, but also capsules and powders. If needed, please feel free to contact us at any time.
|
|
|
Intense physical activity-including high-intensity interval training (HIIT), resistance exercises, and endurance sports-dramatically elevates the production of reactive oxygen species (ROS) within muscle tissues. This ROS surge stems from heightened metabolic demand, particularly during scenarios where oxygen consumption exceeds supply, such as hypoxia (oxygen deficiency) or reperfusion (reoxygenation after ischemia). While ROS at physiological levels act as signaling molecules involved in muscle adaptation, growth, and metabolic regulation, their excessive accumulation triggers oxidative stress. This, in turn, contributes to muscle fatigue, inflammation, and cellular damage, impairing performance and recovery. Glutathione tablet 500 mg (GSH), the body's primary endogenous antioxidant, emerges as a critical defender in this context, mitigating oxidative stress and supporting muscle health.
Brain activity depends on a stable supply of blood sugar. Astrocytes express glucose transporter 1 (GLUT1), which is generally considered to be their main pathway for glucose uptake to maintain metabolic and antioxidant support for neurons. Although GLUT1 deficiency can lead to severe developmental disorders, its role in adult astrocytes is unclear.
Based on this, on May 6, 2025, the Aiman S. Saab research team of the Institute of Pharmacology and Toxicology at the University of Zurich, Switzerland, published "Astrocytic GLUT1 deletion in adult mice enhances glucose metabolism and resilience to stroke" in the journal Nature communications, revealing that the loss of GLUT1 in astrocytes of adult mice enhances glucose metabolism and resistance to stroke.
The authors found that after specifically knocking out GLUT1 in adult mice in astrocytes, both astrocytes and neurons were able to tolerate this loss. Male GLUT1 conditional knockout (cKO) mice maintained normal sensorimotor and memory functions, indicating that the loss of GLUT1 did not impair their behavioral abilities. Despite the lack of GLUT1, astrocytes maintained normal basal glucose levels, but their glucose consumption increased more than twofold, indicating enhanced metabolic activity. After stroke, male GLUT1 cKO mice showed a significant reduction in infarct volume, suggesting that enhanced astrocytic glucose metabolism is neuroprotective. The authors' study reveals the metabolic adaptability of astrocytes to maintain glucose uptake and support functions for neurons even in the absence of their major glucose transporter (GLUT1).
Astrocytes are thought to rely heavily on GLUT1, a key glucose transporter, to ensure glucose uptake and glycolysis. To investigate the role of GLUT1 in glucose metabolism and brain function in adult mice, we generated inducible and astrocyte-specific GLUT1 conditional knockout mice (GLUT1 cKO mice).
GLUT1 gene recombination was induced by tamoxifen treatment in 8- to 10-week-old GLUT1 cKO mice and the experiments were performed approximately 60 days after injection. Littermate control mice also received the same tamoxifen treatment. Given that endothelial cells express high levels of GLUT1, Western blot analysis was performed using decapillary brain homogenates to assess the absence of GLUT1 in GLUT1 cKO mice. The 55 kDa isoform of GLUT1 was abundant in brain microvessels, whereas the 45 kDa isoform expressed in astrocytes was predominant in decapillary brain homogenates.
In forebrain lysates from GLUT1 cKO mice, the expression level of this 45 kDa isoform was reduced by approximately 50% compared to controls, a significant reduction considering that astrocytes only account for approximately 20% of forebrain cells and that other neural cell types also express GLUT1. Immunoblot analysis showed no significant changes in the expression levels of GLUT2, GLUT3, and GLUT4, suggesting that loss of GLUT1 in astrocytes did not affect the expression of these other major glucose transporters
qPCR and RNA-seq analysis of immunoprecipitated samples revealed that the abundance of Slc2a1 transcripts in cKO mice was reduced by 70% compared to controls. RNA-seq analysis of immunoprecipitated samples showed no significant differences in mRNA levels for other GLUTs between genotypes. Adult brain tissue can also utilize circulating lactate and ketone bodies as energy sources to some extent, which enter the brain via monocarboxylate transporter 1. However, no significant changes in the expression levels of Slc16a1 or other major MCTs were found.
Differential gene expression analysis identified a total of 13 differentially expressed genes that were significantly up-regulated or down-regulated between the different genotypes, reflecting a moderate change in the overall translation profile. Gene enrichment analysis revealed some biological processes, such as vacuolar acidification, positive regulation of glial differentiation, and RNA processing. Notably, no significant changes were observed in pathways related to energy metabolism, indicating that the loss of GLUT1 did not significantly affect the translation of metabolism-related genes in astrocytes.
Enhanced glucose metabolism in astrocytes may be neuroprotective in the setting of stroke, possibly by providing neurons with more lactate, an alternative energy source, and by increasing glutathione tablet 500 mg production, which is essential for alleviating oxidative stress. To test this hypothesis, the authors performed thrombin-induced middle artery occlusion surgery (a stroke model) in male GLUT1 cKO mice and their control counterparts.
Laser speckle imaging before and after stroke induction confirmed that the occlusion-induced reduction in cerebral blood flow was similar between the two groups, ensuring that comparisons of stroke injury between genotypes were comparable.
Poststroke weight changes, which reflected overall health and stress levels, did not differ significantly between control and GLUT1 cKO mice. One week after stroke, animals were perfused and brain tissue was removed for analysis of neuronal injury volume.
Results showed that GLUT1 cKO mice had significantly reduced infarct volume (approximately 43% reduction) compared with littermate control mice, suggesting that enhanced astrocyte glucose metabolism caused by GLUT1 deficiency is neuroprotective. Mice of both genotypes showed reactive gliosis: at the edge of the infarct, astrocytes extended processes toward the infarct core and were surrounded by dense round macrophages and microglia. The infarct border zone (0–150 μm from the infarct edge) was characterized by astrocytes with elongated processes toward the core, while the peri-infarct zone (150–500 μm outside the border) contained reactive astrocytes that were less elongated in morphology.
Sholl analysis showed that astrocytes in both genotypes were morphologically similar and elongated in the infarct border zone, while astrocytes in GLUT1 cKO mice had fewer branches in the peri-infarct zone. In contrast, no significant differences in microglial morphology were observed between the two genotypes in this region. The phenotype of less reactive astrocytes in the peri-infarct zone of GLUT1 cKO mice may represent a blunted astrocyte response, which may help to mitigate brain damage and promote neuroprotection.
Glutathione are a popular supplement for boosting cellular antioxidant defenses, but their absorption efficiency has been a topic of debate. Unlike it's natural synthesis in the body (from glycine, glutamate, and cysteine), oral tablets face challenges in bioavailability due to poor intestinal absorption and breakdown by digestive enzymes. Some studies suggest that only a small fraction of orally administered glutathione survives gastrointestinal degradation to enter systemic circulation, limiting its direct effects on raising intracellular glutathione levels. However, newer formulations-such as liposomal glutathione, sublingual tablets, or sustained-release versions-aim to enhance absorption by protecting glutathione from enzymatic degradation or facilitating direct uptake into the bloodstream.
Liposomal glutathione, in particular, encapsulates glutathione in lipid nanoparticles, improving its stability and delivery to cells. Additionally, precursors like N-acetylcysteine (NAC) or whey protein (rich in cysteine) are often preferred for boosting endogenous the production, as they bypass absorption limitations. While they may offer some benefits-particularly in formulations designed to enhance bioavailability-their efficacy varies widely among individuals. Users should consider their specific health goals, potential interactions with medications, and consult healthcare providers to determine if glutathione tablet 500 mg or precursors are the most suitable option for optimizing antioxidant status.
Some studies have highlighted the potent skin-lightening effects associated with the utilization. However, it has also been scrutinized by multiple researchers due to concerns over its inconsistent outcomes and questions regarding its overall effectiveness. The safety of both oral and topical glutathione supplementation remains a critical consideration, particularly with prolonged use. While it is generally regarded as safe in clinical practice, the potential systemic effects of long-term use have not yet been thoroughly researched or studied. Concerns include the possibility of toxicity and interactions with other medications. However, more serious or long-term side effects have not been comprehensively investigated to date. Given the use of it in cosmetic formulation and the enhanced demand for skin-lightening solutions, a detailed literature review is required to evaluate both the benefits and the harms of glutathione supplementation
Frequently Asked Questions
What happens to your body when you start taking glutathione?
+
-
Boosting glutathione may provide many health benefits, including reduction of oxidative stress. Other benefits of glutathione include the potential for improving insulin resistance and psoriasis. It may also help limit the damage from fatty liver disease.
Are there any downsides to taking glutathione?
+
-
Notably, they are associated with an increased likelihood of developing serious health conditions, including a heightened risk of skin cancer, along with other adverse effects, such as premature aging, immune system suppression, and potential allergic reactions or chemical toxicity, depending on the specific product.
Is it really worth it?
+
-
It's worth taking glutathione if you have a deficiency or specific conditions like AIDS, cystic fibrosis, or certain liver/neurological issues, as it's a powerful antioxidant, but most healthy people make enough, so it's best to consult a doctor to see if it's right for you, especially given options like liposomal forms for better absorption. For healthy individuals, increasing precursors (cysteine, glutamate) through diet might be enough, but supplements can help with aging, inflammation, and immune support if levels are low.
Hot Tags: glutathione tablet 500 mg, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale